Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection
about
Antiviral treatment of hepatitis C virus infection and factors affecting efficacyUbiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapy.The role of immunophilins in viral infection.Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.NS5B polymerase inhibitors in phase II clinical trials for HCV infection.
P2860
Q26851810-454844DB-D809-4CEF-8A53-9362A4C77D35Q38115330-57E52909-6AEC-4E0B-AD42-B9D43E2E5744Q38274889-0D00FA72-7B60-40B2-9320-D92DDD0DCB60Q38588798-36605C79-DAFA-4074-B61B-436D18DEA6F4Q38895022-5E3CAFA5-3BC2-44F0-989A-74BDA0C098FAQ41488466-41FB6150-B446-4DC1-9342-F2BF6478466EQ47260158-993F8760-4BBF-4EEF-AC58-161DF22E4298
P2860
Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cyclophilin inhibitors: an eme ...... chronic hepatitis C infection
@en
type
label
Cyclophilin inhibitors: an eme ...... chronic hepatitis C infection
@en
prefLabel
Cyclophilin inhibitors: an eme ...... chronic hepatitis C infection
@en
P2860
P921
P356
P1433
P1476
Cyclophilin inhibitors: an eme ...... chronic hepatitis C infection
@en
P2093
Philippe Gallay
Sam Hopkins
P2860
P304
P356
10.3390/V4112558
P577
2012-10-29T00:00:00Z